192 related articles for article (PubMed ID: 1280495)
1. Evaluation of soluble CD 14 and neopterin as serum parameters of the inflammatory activity of pulmonary sarcoidosis.
Homolka J; Lorenz J; Zuchold HD; Müller-Quernheim J
Clin Investig; 1992 Oct; 70(10):909-16. PubMed ID: 1280495
[TBL] [Abstract][Full Text] [Related]
2. Reduction of monocyte-macrophage activation markers upon anti-CD4 treatment. Decreased levels of IL-1, IL-6, neopterin and soluble CD14 in patients with rheumatoid arthritis.
Horneff G; Sack U; Kalden JR; Emmrich F; Burmester GR
Clin Exp Immunol; 1993 Feb; 91(2):207-13. PubMed ID: 7679058
[TBL] [Abstract][Full Text] [Related]
3. Prolonged interferon-gamma application by subcutaneous infusion in cancer patients: differential response of serum CD14, neopterin, and monocyte HLA class I and II antigens.
Landmann R; Ludwig C; Wesp M; Fisscher A; Obrist R; Knüsli C; Denz H; Obrecht JP
J Interferon Res; 1992 Apr; 12(2):103-11. PubMed ID: 1374454
[TBL] [Abstract][Full Text] [Related]
4. Serum levels of soluble CD163 as a specific marker of macrophage/monocyte activity in sarcoidosis patients.
Tanimura H; Mizuno K; Okamoto H
Sarcoidosis Vasc Diffuse Lung Dis; 2015 Jul; 32(2):99-105. PubMed ID: 26278688
[TBL] [Abstract][Full Text] [Related]
5. Idiopathic pulmonary fibrosis: can cell mediated immunity markers predict clinical outcome?
Meliconi R; Lalli E; Borzì RM; Sturani C; Galavotti V; Gunella G; Miniero R; Facchini A; Gasbarrini G
Thorax; 1990 Jul; 45(7):536-40. PubMed ID: 2118691
[TBL] [Abstract][Full Text] [Related]
6. Soluble CD14 is increased in bronchoalveolar lavage of active sarcoidosis and correlates with alveolar macrophage membrane-bound CD14.
Striz I; Zheng L; Wang YM; Pokorná H; Bauer PC; Costabel U
Am J Respir Crit Care Med; 1995 Feb; 151(2 Pt 1):544-7. PubMed ID: 7531099
[TBL] [Abstract][Full Text] [Related]
7. Urinary neopterin in pulmonary sarcoidosis. Relationship to clinical and biologic assessment of the disease.
Lacronique J; Auzeby A; Valeyre D; Traore BM; Barbosa ML; Soler P; Choudat D; Battesti JP; Touitou Y; Marsac J
Am Rev Respir Dis; 1989 Jun; 139(6):1474-8. PubMed ID: 2543248
[TBL] [Abstract][Full Text] [Related]
8. Expression of CD14 correlates with lung function impairment in pulmonary sarcoidosis.
Pforte A; Schiessler A; Gais P; Beer B; Ehlers M; Schütt C; Ziegler-Heitbrock HW
Chest; 1994 Feb; 105(2):349-54. PubMed ID: 7508361
[TBL] [Abstract][Full Text] [Related]
9. Unconjugated pteridines in bronchoalveolar lavage as indicators of alveolar macrophage activation.
Dhondt JL; Darras A; Mulliez P; Hayte JM; Crinquette J
Chest; 1989 Feb; 95(2):348-51. PubMed ID: 2914487
[TBL] [Abstract][Full Text] [Related]
10. Phenotypic analysis of lymphocytes and monocytes/macrophages in peripheral blood and bronchoalveolar lavage fluid from patients with pulmonary sarcoidosis.
Wahlström J; Berlin M; Sköld CM; Wigzell H; Eklund A; Grunewald J
Thorax; 1999 Apr; 54(4):339-46. PubMed ID: 10092696
[TBL] [Abstract][Full Text] [Related]
11. Elevated serum neopterin levels in sarcoidosis.
Eklund A; Blaschke E
Lung; 1986; 164(6):325-32. PubMed ID: 3027463
[No Abstract] [Full Text] [Related]
12. Relationship between serum neopterin and lymphocytic alveolitis in sarcoidosis.
Blaschke E; Eklund A; Persson U
Sarcoidosis; 1988 Mar; 5(1):25-30. PubMed ID: 2837821
[TBL] [Abstract][Full Text] [Related]
13. Shed soluble ICAM-1 molecules in bronchoalveolar lavage cell supernatants and serum of patients with pulmonary sarcoidosis.
Bäumer I; Zissel G; Schlaak M; Müller-Quernheim J
Lung; 1997; 175(2):105-16. PubMed ID: 9042667
[TBL] [Abstract][Full Text] [Related]
14. Sarcoidosis: TNF-alpha release from alveolar macrophages and serum level of sIL-2R are prognostic markers.
Ziegenhagen MW; Benner UK; Zissel G; Zabel P; Schlaak M; Müller-Quernheim J
Am J Respir Crit Care Med; 1997 Nov; 156(5):1586-92. PubMed ID: 9372680
[TBL] [Abstract][Full Text] [Related]
15. Phenotypic markers of alveolar macrophage maturation in pulmonary sarcoidosis.
Stríz I; Wang YM; Teschler H; Sorg C; Costabel U
Lung; 1993; 171(5):293-303. PubMed ID: 7692188
[TBL] [Abstract][Full Text] [Related]
16. Increased soluble CD14 serum levels and altered CD14 expression of peripheral blood monocytes in HIV-infected patients.
Nockher WA; Bergmann L; Scherberich JE
Clin Exp Immunol; 1994 Dec; 98(3):369-74. PubMed ID: 7527738
[TBL] [Abstract][Full Text] [Related]
17. Inflammatory BAL-fluid and serum parameters in HLA DR17 positive vs. DR17 negative patients with pulmonary sarcoidosis.
Planck A; Eklund A; Grunewald J
Sarcoidosis Vasc Diffuse Lung Dis; 2001 Mar; 18(1):64-9. PubMed ID: 11354549
[TBL] [Abstract][Full Text] [Related]
18. YKL-40, Soluble IL-2 Receptor, Angiotensin Converting Enzyme and C-Reactive Protein: Comparison of Markers of Sarcoidosis Activity.
Uysal P; Durmus S; Sozer V; Gelisgen R; Seyhan EC; Erdenen F; Simsek G; Uzun H
Biomolecules; 2018 Aug; 8(3):. PubMed ID: 30154391
[TBL] [Abstract][Full Text] [Related]
19. Activation of alveolar macrophages in pulmonary sarcoidosis: lack of correlation with serum angiotensin-converting enzyme activity.
Sugimoto M; Nishi R; Ando M; Nakashima H; Araki S
Jpn J Med; 1986 May; 25(2):135-43. PubMed ID: 3018335
[TBL] [Abstract][Full Text] [Related]
20. Does serum angiotensin converting enzyme reflect intensity of alveolitis in sarcoidosis?
Cohen RD; Bunting PS; Meindok HO; Chamberlain DW; Rebuck AS
Thorax; 1985 Jul; 40(7):497-500. PubMed ID: 2994247
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
